BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD, Inc., announced plans to amend its Regulation A offering to raise the price of its common stock from $0.0001 to $0.001 per share, according to a release distributed through NEWMEDIAWIRE. The proposed tenfold increase, subject to SEC filing and qualification requirements, would mean the company issues 90% fewer shares to raise an equivalent amount of gross equity capital.
The practical effect is significant for a company at UNLOCKD's stage. At the existing price, raising $100,000 in gross proceeds would require issuing roughly 1 billion common shares; at the proposed price, the same amount would require about 100 million shares. Management frames the adjustment as a way to limit potential shareholder dilution and preserve authorized share capacity for acquisitions, product development and commercialization.
Chief Executive Officer John P. Gorst said the original price was set during an earlier phase of restructuring, when access to capital was constrained and the company was stabilizing operations and addressing legacy obligations. "We believe continuing to issue equity at the original price is no longer appropriate for the direction we are taking the Company," Gorst said, adding that management can control the terms on which it issues new equity even though it cannot control the market price.
The company has spent 2026 assembling a consumer health and wellness platform through two approaches: acquiring undercapitalized or distressed brands and intellectual property, and pursuing revenue-generating acquisitions that add scale and distribution. Completed deals include EVERMIND, Ancient Extracts USA and the 1ENERGY consumer brand assets. Ancient Extracts USA is the current revenue-generating operating brand, while EVERMIND and 1ENERGY provide intellectual property and future commercialization opportunities. UNLOCKD also announced a binding letter of intent to acquire Ancient Extracts UK, a transaction it says could add nearly $1 million in annualized revenue upon closing, subject to financing, due diligence, audit and definitive documentation.
For investors, the proposal matters because the offering price is a management-determined financing term, not an independent valuation or an indication of expected trading price. The company acknowledged that its ability to raise capital at the revised price depends on investor demand and market conditions, and that future equity issuances may still dilute existing shareholders. The amendment must be filed with the U.S. Securities and Exchange Commission, and no securities will be sold at the revised price until qualification requirements are satisfied. Investors are directed to review the current offering circular and risk factors through the SEC's EDGAR database at www.sec.gov.
For the broader small-cap and business services market, the move illustrates a financing discipline question facing distressed or restructuring companies: whether to keep issuing equity at legacy prices that consume authorized shares, or to reprice offerings as operations mature. UNLOCKD said it expects to provide further details through applicable SEC filings and corporate communications.

